Rituximab-Containing Treatment Regimens May Imply a Long-Term Risk for Difficult-To-Treat Chronic Hepatitis E

Rituximab-Containing Treatment Regimens May Imply a Long-Term Risk for Difficult-To-Treat Chronic Hepatitis E

Hepatitis E virus (HEV) infection is an emerging disease in industrialized countries which is usually characterized by a self-limited course. However, there is an increased risk of HEV persistence in immunocompromised risk populations, comprising patients following solid organ transplantation or hem...

Full description

Bibliographic Details
Main Authors: Marten Schulz, Paula Biedermann, Claus-Thomas Bock, Jörg Hofmann, Mira Choi, Frank Tacke, Leif Gunnar Hanitsch, Tobias Mueller
Format: Article
Language:English
Published: MDPI AG 2020-01-01
Series:International Journal of Environmental Research and Public Health
Subjects:
hepatitis e
rituximab
ribavirin resistance
hypogammaglobulinemia: cd4+ t cell lymphopenia
Online Access:https://www.mdpi.com/1660-4601/17/1/341

Internet

https://www.mdpi.com/1660-4601/17/1/341

Similar Items